<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Current Computer-Aided Drug Design</journal-id><journal-title-group><journal-title xml:lang="en">Current Computer-Aided Drug Design</journal-title><trans-title-group xml:lang="ru"><trans-title>Current Computer-Aided Drug Design</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1573-4099</issn><issn publication-format="electronic">1875-6697</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">643984</article-id><article-id pub-id-type="doi">10.2174/1573409919666230503094400</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Chemistry</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">DFT, Molecular Docking, Bioactivity and ADME Analyses of Vic-dioxim Ligand Containing Hydrazone Group and its Zn(II) Complex</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gökçe Çalişkan</surname><given-names>Şerife</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Department of Physics, Faculty of Sciences,, Adnan Menderes University</institution></aff><pub-date date-type="pub" iso-8601-date="2024-03-01" publication-format="electronic"><day>01</day><month>03</month><year>2024</year></pub-date><volume>20</volume><issue>3</issue><issue-title xml:lang="ru"/><fpage>264</fpage><lpage>273</lpage><history><date date-type="received" iso-8601-date="2025-01-07"><day>07</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://rjeid.com/1573-4099/article/view/643984">https://rjeid.com/1573-4099/article/view/643984</self-uri><abstract xml:lang="en"><p id="idm46041443807168">Background:Cancer is one of the diseases affecting a large population worldwide and resulting in death. Finding new anti-cancer drugs that are target-focused and have low toxicity is of great importance.</p><p id="idm46041443811168">Objective:This study aimed to investigate the effects of vic-dioxime derivatives carrying hydrazone group and its Zn(II) complex on cancer using molecular docking, bioactivity and quantum chemical calculations.</p><p id="idm46041443815136">Methods:Molecular docking studies were performed on epidermal growth factor receptor and vascular endothelial growth factor receptor 2 target proteins. Furthermore, molecular geometry was performed, and the frontier molecular orbitals, Mulliken charges and molecular electron density distribution were evaluated using density functional theory. Also, the bioactivity parameters of the compounds were evaluated, and ADME analysis was performed using web-based tools.</p><p id="idm46041443820192">Results:Higher binding affinity was observed for Zn(II) complex with target proteins vascular endothelial growth factor receptor 2 and against epidermal growth factor receptor when compared with LH2. Only the Zn(II) complex against the epidermal growth factor receptor had ligand efficiency and fit quality in the valid range. Furthermore, LH2 has the most potent electrophilic ability (acceptor) among other compounds. Moreover, both LH2 and Zn(II) complexes strongly satisfy Lipinskis rule of five.</p><p id="idm46041443829568">Conclusion:In conclusion, these novel compounds, especially Zn(II) complex, can be new candidates for anticancer drug development studies which are target-focused and have low toxicity.</p></abstract><kwd-group xml:lang="en"><kwd>Cancer</kwd><kwd>hydrazone</kwd><kwd>molecular docking</kwd><kwd>bioactivity</kwd><kwd>density functional theory</kwd><kwd>ADME analysis.</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Yaseen, Y.; Kubba, A.; Shihab, W.; Tahtamouni, L. Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities. Pharmacia, 2022, 69(3), 595-614. doi: 10.3897/pharmacia.69.e86504</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Haider, K.; Rehman, S.; Pathak, A.; Najmi, A.K.; Yar, M.S. Advances in 2‐substituted benzothiazole scaffold‐based chemotherapeutic agents. Arch. Pharm., 2021, 354(12), 2100246. doi: 10.1002/ardp.202100246 PMID: 34467567</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Amadio, M.; Govoni, S.; Pascale, A. Targeting VEGF in eye neovascularization: Whats new? Pharmacol. Res., 2016, 103, 253-269. doi: 10.1016/j.phrs.2015.11.027 PMID: 26678602</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Alkahtani, H.M.; Alanazi, M.M.; Aleanizy, F.S.; Alqahtani, F.Y.; Alhoshani, A.; Alanazi, F.E.; Almehizia, A.A.; Abdalla, A.N.; Alanazi, M.G.; El-Azab, A.S.; Abdel-Aziz, A.A.M. Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies. Saudi Pharm. J., 2019, 27(5), 682-693. doi: 10.1016/j.jsps.2019.04.003 PMID: 31297023</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Altamimi, A.S.; El-Azab, A.S.; Abdelhamid, S.G.; Alamri, M.A.; Bayoumi, A.H.; Alqahtani, S.M.; Alabbas, A.B.; Altharawi, A.I.; Alossaimi, M.A.; Mohamed, M.A. Synthesis, anticancer screening of some novel trimethoxy quinazolines and VEGFR2, EGFR tyrosine kinase inhibitors assay; molecular docking studies. Molecules, 2021, 26(10), 2992. doi: 10.3390/molecules26102992 PMID: 34069962</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Shakdofa, M.M.E.; Morsy, N.A.; Rasras, A.J.; Al-Hakimi, A.N.; Shakdofa, A.M.E. Synthesis, characterization, and density functional theory studies of hydrazoneoxime ligand derived from 2,4,6‐trichlorophenyl hydrazine and its metal complexes searching for new antimicrobial drugs. Appl. Organomet. Chem., 2021, 35(2), e6111. doi: 10.1002/aoc.6111</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Sarikavakli, N. Morphological and termal studies of synthesized ethanehydroximohydrazide (1Z, 2E)-N′-(1Z)-1-biphenyl-4-yl-2-bromoethylidene-2-(hydroxyimino) and its metal complexes. Dialogo J., 2016, 3, 163-172. doi: 10.18638/dialogo.2016.3.1.15</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Jurisson, S.S.; Lydon, J.D. Potential technetium small molecule radiopharmaceuticals. Chem. Rev., 1999, 99(9), 2205-2218. doi: 10.1021/cr980435t PMID: 11749479</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Sevagapandian, S.; Rajagopal, G.; Nehru, K.; Athappan, P. Copper(II), nickel(II), cobalt(II) and oxovanadium(IV) complexes of substituted β-hydroxyiminoanilides. Trans. Met. Chem., 2000, 25(4), 388-393. doi: 10.1023/A:1007067326655</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Sellmann, D.; Utz, J.; Heinemann, F.W. Transition-metal complexes with sulfur ligands. electron-rich Fe and Ru complexes with MN2S3 cores containing the new pentadentate ligand N2H2S32- (= 2,2-Bis(2-mercaptophenylamino)diethyl sulfide(2−)). Inorg. Chem., 1999, 38(3), 459-466. doi: 10.1021/ic980383q PMID: 11673949</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Laranjeira, M.C.M.; Marusak, R.A.; Lappin, A.G. Driving force effects in proton coupled electron transfer. Inorg. Chim. Acta, 2000, 300-302, 186-190. doi: 10.1016/S0020-1693(99)00558-7</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rakha, T.H. Mononuclear and binuclear chelates of biacetylmonoxime picolinoylhydrazone. Trans. Met. Chem., 1999, 24(6), 659-665. doi: 10.1023/A:1006936101143</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ragavendran, J.V.; Sriram, D.; Patel, S.K.; Reddy, I.V.; Bharathwajan, N.; Stables, J.; Yogeeswari, P. Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore. Eur. J. Med. Chem., 2007, 42(2), 146-151. doi: 10.1016/j.ejmech.2006.08.010 PMID: 17011080</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ainscough, E.W.; Brodie, A.M.; Dobbs, A.J.; Ranford, J.D.; Waters, J.M. Antitumour copper(II) salicylaldehyde benzoylhydrazone (H2sb) complexes: physicochemical properties and the single-crystal X-ray structures of Cu(H2sb)(CCl3CO2)22 and Cu(Hsb) (ClO4) (C2H5OH)2 and the related salicylaldehyde acetylhydrazone (H2sa) complex, Cu(Hsa)Cl(H2O)H2O. Inorg. Chim. Acta, 1998, 267(1), 27-38. doi: 10.1016/S0020-1693(97)05548-5</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Abou-Seri, S.M.; Eissa, A.A.M.; Behery, M.G.M.; Omar, F.A. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2. Bioorg. Chem., 2021, 116, 105334. doi: 10.1016/j.bioorg.2021.105334 PMID: 34534755</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Govindaiah, S.; Naha, S.; Madhuchakrapani Rao, T.; Revanasiddappa, B.C.; Srinivasa, S.M.; Parashuram, L.; Velmathi, S.; Sreenivasa, S. Sulfated magnesium zirconate catalyzed synthesis, antimicrobial, antioxidant, anti-inflammatory, and anticancer activity of benzodthiazole-hydrazone analogues and its molecular docking. Results Chem., 2021, 3, 100197. doi: 10.1016/j.rechem.2021.100197</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Sarikavakli, N.; İrez, G. Synthesis and complex formation of some novel vicdioxime derivatives of hydrazones. Turk. J. Chem., 2005, 29(1), 107-116.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Sarıkavaklı N.; Çakıcı H.T. Synthesis and characterization of Co(II), Ni(II), Cu(II) and Zn(II) complexes of glyoxime hydrazone. Asian J. Chem., 2011, 23(3), 1321.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H.P.; Izmaylov, A.F.; Bloino, J.; Zheng, G.; Sonnenberg, J.L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J.A., Jr; Peralta, J.E. Gaussian 09, Revision B.01; Gaussian Inc.: Wallingford, 2010.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Becke, A.D. Density‐functional thermochemistry. III. The role of exact exchange. J. Chem. Phys., 1993, 98(7), 5648-5652. doi: 10.1063/1.464913</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Miehlich, B.; Savin, A.; Stoll, H.; Preuss, H. Results obtained with the correlation energy density functionals of becke and Lee, Yang and Parr. Chem. Phys. Lett., 1989, 157(3), 200-206. doi: 10.1016/0009-2614(89)87234-3</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Al Zoubi, W.; Ko, Y.G. Enhanced corrosion protection performance by organic-inorganic materials containing thiocarbonyl compounds. Sci. Rep., 2018, 8(1), 10925. doi: 10.1038/s41598-018-29299-5 PMID: 30026470</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Koopmans, T. Über die zuordnung von wellenfunktionen und eigenwerten zu den einzelnen elektronen eines. Atoms. Physica, 1934, 1(1-6), 104-113. doi: 10.1016/S0031-8914(34)90011-2</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Allal, H.; Belhocine, Y.; Zouaoui, E. Computational study of some thiophene derivatives as aluminium corrosion inhibitors. J. Mol. Liq., 2018, 265, 668-678. doi: 10.1016/j.molliq.2018.05.099</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Trott, O.; Olson, A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2009, 31(2), 455-461. doi: 10.1002/jcc.21334 PMID: 19499576</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Onawole, A.T.; Kolapo, T.U.; Sulaiman, K.O.; Adegoke, R.O. Structure based virtual screening of the Ebola virus trimeric glycoprotein using consensus scoring. Comput. Biol. Chem., 2018, 72, 170-180. doi: 10.1016/j.compbiolchem.2017.11.006 PMID: 29361403</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Hopkins, A.L.; Groom, C.R.; Alex, A. Ligand efficiency: A useful metric for lead selection. Drug Discov. Today, 2004, 9(10), 430-431. doi: 10.1016/S1359-6446(04)03069-7 PMID: 15109945</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Reynolds, C.H.; Bembenek, S.D.; Tounge, B.A. The role of molecular size in ligand efficiency. Bioorg. Med. Chem. Lett., 2007, 17(15), 4258-4261. doi: 10.1016/j.bmcl.2007.05.038 PMID: 17532632</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Schultes, S.; de Graaf, C.; Haaksma, E.E.J.; de Esch, I.J.P.; Leurs, R.; Krämer, O. Ligand efficiency as a guide in fragment hit selection and optimization. Drug Discov. Today. Technol., 2010, 7(3), e157-e162. doi: 10.1016/j.ddtec.2010.11.003 PMID: 24103767</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Available From: www.molinspiration.com</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Lee, C.; Yang, W.; Parr, R.G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B Condens. Matter, 1988, 37(2), 785-789. doi: 10.1103/PhysRevB.37.785 PMID: 9944570</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ferdous, J.M.A.; Kawsar, S. Thermochemical, molecular docking and ADMET studies of some methyl α-D-glucopyranoside derivatives. Chittagong Univ. J. Sci., 2021, 42(1), 58-83. doi: 10.3329/cujs.v42i1.54238</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Rupa, S.A.; Moni, M.R.; Patwary, M.A.M.; Mahmud, M.M.; Haque, M.A.; Uddin, J.; Abedin, S.M.T. Synthesis of novel tritopic hydrazine ligands: spectroscopy, biological activity, DFT, and molecular docking studies. Molecules, 2022, 27(5), 1656. doi: 10.3390/molecules27051656 PMID: 35268756</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Sulaiman, K.O.; Kolapo, T.U.; Onawole, A.T.; Islam, M.A.; Adegoke, R.O.; Badmus, S.O. Molecular dynamics and combined docking studies for the identification of Zaire ebola virus inhibitors. J. Biomol. Struct. Dyn., 2019, 37(12), 3029-3040. doi: 10.1080/07391102.2018.1506362 PMID: 30058446</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Verna, A. Lead finding from phyllanthusdebelis with hepatoprotective potentials. Asi. Pac. J. Trop. Biomed., 2012, 1, 735-737.</mixed-citation></ref></ref-list></back></article>
